全文获取类型
收费全文 | 4643篇 |
免费 | 428篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 218篇 |
妇产科学 | 70篇 |
基础医学 | 712篇 |
口腔科学 | 82篇 |
临床医学 | 561篇 |
内科学 | 972篇 |
皮肤病学 | 50篇 |
神经病学 | 263篇 |
特种医学 | 180篇 |
外科学 | 561篇 |
综合类 | 96篇 |
一般理论 | 13篇 |
预防医学 | 461篇 |
眼科学 | 42篇 |
药学 | 305篇 |
中国医学 | 3篇 |
肿瘤学 | 471篇 |
出版年
2023年 | 25篇 |
2022年 | 32篇 |
2021年 | 94篇 |
2020年 | 53篇 |
2019年 | 92篇 |
2018年 | 85篇 |
2017年 | 68篇 |
2016年 | 71篇 |
2015年 | 93篇 |
2014年 | 121篇 |
2013年 | 181篇 |
2012年 | 243篇 |
2011年 | 227篇 |
2010年 | 150篇 |
2009年 | 168篇 |
2008年 | 195篇 |
2007年 | 230篇 |
2006年 | 195篇 |
2005年 | 177篇 |
2004年 | 181篇 |
2003年 | 172篇 |
2002年 | 149篇 |
2001年 | 131篇 |
2000年 | 188篇 |
1999年 | 146篇 |
1998年 | 85篇 |
1997年 | 79篇 |
1996年 | 74篇 |
1995年 | 63篇 |
1994年 | 91篇 |
1993年 | 66篇 |
1992年 | 94篇 |
1991年 | 98篇 |
1990年 | 97篇 |
1989年 | 95篇 |
1988年 | 82篇 |
1987年 | 69篇 |
1986年 | 75篇 |
1985年 | 57篇 |
1984年 | 48篇 |
1983年 | 40篇 |
1982年 | 40篇 |
1981年 | 38篇 |
1980年 | 29篇 |
1979年 | 32篇 |
1978年 | 23篇 |
1977年 | 25篇 |
1976年 | 24篇 |
1969年 | 26篇 |
1968年 | 26篇 |
排序方式: 共有5111条查询结果,搜索用时 15 毫秒
101.
102.
103.
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study 总被引:1,自引:0,他引:1
Noone PG Hamblett N Accurso F Aitken ML Boyle M Dovey M Gibson R Johnson C Kellerman D Konstan MW Milgram L Mundahl J Retsch-Bogort G Rodman D Williams-Warren J Wilmott RW Zeitlin P Ramsey B;Cystic Fibrosis Therapeutics Development Research Group 《Pediatric pulmonology》2001,32(2):122-128
Cystic fibrosis (CF) is characterized by defective cystic fibrosis transmembrane regulator (CFTR) expression and function, associated with abnormal ion transport and mucociliary clearance, and clinical lung disease. Triphosphate nucleotides such as uridine-5'-triphosphate (UTP) and INS 365, may be useful for CF through actions, mediated via P2Y(2) extracellular receptors, on chloride and liquid secretion, and ciliary beat frequency. INS 365 may offer chemical stability advantages over UTP. In a randomized, double-blind, multicenter phase I study, we studied the safety and maximally tolerated dose of escalating, single doses of aerosolized INS 365, in adult and pediatric patients with mild to moderate CF lung disease (FEV(1) > or = 45% predicted). In four successive dose cohorts of adult patients (n = 12 per cohort, age > or = 18 years) and four successive pediatric dose cohorts (n = 12 per cohort, age 5-12 years), patients were randomized 3:1 active/placebo (0.9% saline) to evaluate doses of 20, 40, 80, and 100 mg INS 365 delivered by nebulizer (Pari Star ). Sputum was collected pre- and post-dosing to obtain preliminary results on clinical efficacy. After each dose cohort, a Data Safety Monitoring Committee (DSMC) reviewed the data. Forty-eight adult and 36 pediatric patients completed the protocol (up to 100 mg for adults, 80 mg for pediatric patients). The predominant adverse events were cough, wheezing, chest tightness, and a decrease in FEV(1) (occurring in 8/48 adults, and 5/36 pediatric patients), which occurred predominantly in the 80-mg and 100-mg dose cohorts. Though a few adult patients had a tendency to increase sputum production, there was little consistent effect noted on sputum production in this acute, single-dose study. The data suggest that aerosolized INS 365 is safe when delivered at single doses of up to 40 mg in adults and children with CF, but that higher doses are unlikely to be tolerated. 相似文献
104.
105.
106.
107.
BACKGROUND & AIMS: Shwachman syndrome is an inherited condition with multisystemic abnormalities, including exocrine pancreatic dysfunction. The aim of this study was to evaluate the occurrence and progression of features in a large cohort of patients. METHODS: Clinical records of 25 patients with Shwachman syndrome were reviewed. RESULTS: Mean birth weight (2.92 +/- 0.51 kg) was at the 25th percentile. However, by 6 months of age, mean heights and weights were less than the 5th percentile. After 6 months of age, growth velocity was normal. Severe fat maldigestion due to pancreatic insufficiency was present in early life (fecal fat, 26% +/- 17% of fat intake; age, < 2 years). Serial assessment of exocrine pancreatic function showed persistent deficits of enzyme secretion, but 45% of patients showed moderate age-related improvements leading to pancreatic sufficiency. Neutropenia was the most common hematologic abnormality (88%), but leukopenia, thrombocytopenia, and anemia were also frequently encountered. Patients with hypoplasia of all three bone marrow cellular lines (n = 11) had the worst prognosis; 5 patients died, 2 of sepsis and 3 of acute myelogenous leukemia. Other findings included hepatomegaly and/or abnormal liver function test results and skeletal abnormalities. CONCLUSIONS: A wide and varied spectrum of phenotypic abnormalities among patients with Shwachman syndrome is described. Pancreatic acinar dysfunction is an invariable abnormality. Patients with severe bone marrow involvement may have a guarded prognosis. (Gastroenterology 1996 Dec;111(6):1593-602) 相似文献
108.
X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox 总被引:3,自引:0,他引:3
Chronic granulomatous disease (CGD) is an inherited immunodeficiency resulting from the inability of an individual's phagocytes to produce superoxide anions because of defective NADPH oxidase. The disease may be treated by bone marrow transplantation and as such is a candidate for somatic gene therapy. Two thirds of patients have defects in an X- linked gene (X-CGD) encoding gp91-phox, the large subunit of the membrane cytochrome b-245 component of NADPH oxidase. Epstein-Barr virus-transformed B-cell lines from patients with CGD provide a model system for the disease. We have used retrovirus-mediated expression of gp91-phox to reconstitute functionally NADPH oxidase activity in B-cell lines from three unrelated patients with X-CGD. The protein is glycosylated and membrane associated, and the reconstituted oxidase is appropriately activated via protein kinase C. The kinetics of superoxide production by such reconstituted cells is similar to that of normal B-cell lines. These data show the potential of gene therapy for this disease. 相似文献
109.
110.
Nuntra Suwantarat Mayer Rubin Latetia Bryan Tsigereda Tekle Michael P. Boyle Karen C. Carroll Mark T. Jennings 《Diagnostic microbiology and infectious disease》2018,90(4):296-299